Breaking News Instant updates and real-time market news.

VVV

Valvoline

$29.53 /

+0.895 (+3.13%)

04:38
03/09/22
03/09
04:38
03/09/22
04:38

Valvoline downgraded to Neutral from Overweight at JPMorgan

JPMorgan analyst Jeffrey Zekauskas downgraded Valvoline to Neutral from Overweight with a price target of $30, down from $39. The analyst continues to believe that the longer-term direction of Valvoline is the separation of the two businesses of Valvoline into a free standing Quick Change operation and a Global Lubricant business. However, oil prices have risen sharply, and the company will need to offset the cost inflation with new price increases, Zekauskas tells investors in a research note. He believes Valvoline shares may be pushed lower in the event of delays and as raw material issues play out.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Avis Budget chairman buys $4.9M in common stock » 19:13
05/26/22
05/26
19:13
05/26/22
19:13
CAR

Avis Budget

$185.03 /

+6.06 (+3.39%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

05/04/22 Deutsche Bank
Avis Budget price target raised to $238 from $193 at Deutsche Bank
04/26/22 Deutsche Bank
Hertz named short-term buy idea at Deutsche Bank
04/20/22 Barclays
Barclays upgrades Avis to neutral on 'constructive' rental stance
04/20/22 Barclays
Avis Budget upgraded to Equal Weight from Underweight at Barclays
CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

CAR Avis Budget
$185.03 /

+6.06 (+3.39%)

Hot Stocks
Myriad Genetics to present multiple genetic studies in cancer treatment at ASCO » 19:04
05/26/22
05/26
19:04
05/26/22
19:04
MYGN

Myriad Genetics

$21.15 /

-0.05 (-0.24%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

MYGN Myriad Genetics
$21.15 /

-0.05 (-0.24%)

Earnings
Taro Pharmaceutical reports Q4 EPS 73c vs. (78c) last year » 19:01
05/26/22
05/26
19:01
05/26/22
19:01
TARO

Taro Pharmaceutical

$34.54 /

-2.25 (-6.12%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TARO Taro Pharmaceutical
$34.54 /

-2.25 (-6.12%)

TARO Taro Pharmaceutical
$34.54 /

-2.25 (-6.12%)

01/31/22 H.C. Wainwright
Taro Pharmaceutical price target lowered to $73 from $75 at H.C. Wainwright
01/18/22 H.C. Wainwright
Taro Pharmaceutical price target lowered to $75 from $82 at H.C. Wainwright
07/28/21 H.C. Wainwright
Taro Pharmaceutical price target raised to $82 from $80 at H.C. Wainwright
Hot Stocks
Biomea Fusion to present new preclinical data on BMF-219 at ASCO » 19:00
05/26/22
05/26
19:00
05/26/22
19:00
BMEA

Biomea Fusion

$5.20 /

+0.03 (+0.58%)

Biomea Fusion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

05/17/22 Piper Sandler
Biomea Fusion price target lowered to $25 from $27 at Piper Sandler
01/12/22 H.C. Wainwright
Biomea Fusion initiated with a Buy at H.C. Wainwright
12/16/21 Oppenheimer
Biomea Fusion initiated with an Outperform at Oppenheimer
BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

BMEA Biomea Fusion
$5.20 /

+0.03 (+0.58%)

Recommendations
Equinix price target lowered to $770 from $825 at BMO Capital » 18:57
05/26/22
05/26
18:57
05/26/22
18:57
EQIX

Equinix

$669.92 /

-18.56 (-2.70%)

BMO Capital analyst Ari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQIX Equinix
$669.92 /

-18.56 (-2.70%)

EQIX Equinix
$669.92 /

-18.56 (-2.70%)

05/24/22 Stifel
Equinix added to 'Select List' on selloff at Stifel
04/29/22 JPMorgan
Equinix price target raised to $880 from $860 at JPMorgan
04/25/22 Credit Suisse
Equinix price target raised to $714 from $673 at Credit Suisse
04/08/22 Deutsche Bank
Equinix price target raised to $785 from $780 at Deutsche Bank
EQIX Equinix
$669.92 /

-18.56 (-2.70%)

EQIX Equinix
$669.92 /

-18.56 (-2.70%)

Hot Stocks
Mereo BioPharma to present updated Phase 1b/2 data on Etigilimab and Nivolumab » 18:57
05/26/22
05/26
18:57
05/26/22
18:57
MREO

Mereo BioPharma

/

+

Mereo BioPharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MREO Mereo BioPharma
/

+

Hot Stocks
Affimed to present on three AFM24 clinical trial designs at ASCO 2022 » 18:55
05/26/22
05/26
18:55
05/26/22
18:55
AFMD

Affimed

$3.15 /

-0.02 (-0.63%)

Affimed announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AFMD Affimed
$3.15 /

-0.02 (-0.63%)

AFMD Affimed
$3.15 /

-0.02 (-0.63%)

04/11/22 Cantor Fitzgerald
Affimed AFM13 + NK combination data exceed expectations, says Cantor Fitzgerald
03/30/22 Piper Sandler
Affimed initiated with an Overweight at Piper Sandler
02/23/22 Cantor Fitzgerald
Affimed initiated with an Overweight at Cantor Fitzgerald
02/23/22 Cantor Fitzgerald
Affimed initiated with an Overweight at Cantor Fitzgerald
  • 13
    Apr
AFMD Affimed
$3.15 /

-0.02 (-0.63%)

Hot Stocks
Oncternal Therapeutics presents interim data for Zilovertamab+Ibrutinib at ASCO » 18:51
05/26/22
05/26
18:51
05/26/22
18:51
ONCT

Oncternal Therapeutics

/

+

Oncternal Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONCT Oncternal Therapeutics
/

+

ONCT Oncternal Therapeutics
/

+

05/10/22 Maxim
Oncternal Therapeutics initiated with a Buy at Maxim
02/24/22 BTIG
Oncternal Therapeutics initiated with a Buy at BTIG
02/24/22 BTIG
Oncternal Therapeutics initiated with a Buy at BTIG
ONCT Oncternal Therapeutics
/

+

ONCT Oncternal Therapeutics
/

+

Hot Stocks
Puma Biotechnology to present two abstracts on neratinib at ASCO Meeting » 18:49
05/26/22
05/26
18:49
05/26/22
18:49
PBYI

Puma Biotechnology

$1.95 /

+0.035 (+1.83%)

Puma Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

05/06/22 H.C. Wainwright
Puma Biotechnology price target lowered to $12 from $14 at H.C. Wainwright
09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

PBYI Puma Biotechnology
$1.95 /

+0.035 (+1.83%)

Hot Stocks
Invitae to present eight studies at ASCO » 18:48
05/26/22
05/26
18:48
05/26/22
18:48
NVTA

Invitae

$3.50 /

+0.095 (+2.79%)

Invitae "announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVTA Invitae
$3.50 /

+0.095 (+2.79%)

NVTA Invitae
$3.50 /

+0.095 (+2.79%)

05/04/22 Raymond James
Invitae price target lowered to $8.50 from $10.50 at Raymond James
02/28/22 Raymond James
Invitae price target lowered to $15 from $36 at Raymond James
11/09/21 Wells Fargo
Invitae price target lowered to $25 from $35 at Wells Fargo
10/14/21 Cowen
Invitae coverage transferred at Cowen
NVTA Invitae
$3.50 /

+0.095 (+2.79%)

NVTA Invitae
$3.50 /

+0.095 (+2.79%)

Hot Stocks
Arbutus Biopharma to present data from preclinical study of PD-L1 inhibitor » 18:47
05/26/22
05/26
18:47
05/26/22
18:47
ABUS

Arbutus Biopharma

$2.31 /

+0.055 (+2.44%)

Arbutus Biopharma's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

03/14/22 H.C. Wainwright
Arbutus Biopharma price target raised to $8.50 from $8 at H.C. Wainwright
03/04/22 Chardan
Arbutus Biopharma price target raised to $6 from $5.50 at Chardan
12/29/21 Jefferies
Arbutus Biopharma assumed with a Hold at Jefferies
12/13/21 H.C. Wainwright
H.C. Wainwright sees Arbutus' $300M-plus licensing deal for AB-729 as low-risk
ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

ABUS Arbutus Biopharma
$2.31 /

+0.055 (+2.44%)

Hot Stocks
Elevation Oncology to present initial Seribantumab data at ASCO » 18:46
05/26/22
05/26
18:46
05/26/22
18:46
ELEV

Elevation Oncology

$3.35 /

-0.62 (-15.64%)

Elevation Oncology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELEV Elevation Oncology
$3.35 /

-0.62 (-15.64%)

ELEV Elevation Oncology
$3.35 /

-0.62 (-15.64%)

05/06/22 Wedbush
Elevation Oncology price target lowered to $15 from $21 at Wedbush
03/04/22 Wedbush
Elevation Oncology price target lowered to $21 from $27 at Wedbush
12/23/21
Fly Intel: Top five analyst initiations
12/23/21 H.C. Wainwright
Elevation Oncology initiated with a Buy at H.C. Wainwright
ELEV Elevation Oncology
$3.35 /

-0.62 (-15.64%)

  • 25
    Jun
Hot Stocks
PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO » 18:42
05/26/22
05/26
18:42
05/26/22
18:42
PDSB

PDS Biotechnology

$4.99 /

-0.06 (-1.19%)

PDS Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

05/13/22 Alliance Global Partners
PDS Biotechnology price target lowered to $16 from $18 at Alliance Global Partners
10/21/21 H.C. Wainwright
H.C. Wainwright says PDS Biotechnology temporary hold shouldn't spark concerns
08/12/21 H.C. Wainwright
PDS Biotechnology price target lowered to $15 from $20 at H.C. Wainwright
06/28/21 Cantor Fitzgerald
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald
PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

  • 15
    Jun
PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

Hot Stocks
Gracell to present updated clinical data on GC012F in multiple myeloma » 18:40
05/26/22
05/26
18:40
05/26/22
18:40
GRCL

Gracell

$3.00 /

-0.045 (-1.48%)

Gracell Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRCL Gracell
$3.00 /

-0.045 (-1.48%)

GRCL Gracell
$3.00 /

-0.045 (-1.48%)

04/04/22 BTIG
BTIG starts Gracell at Buy, sees stock trading at 'significant discount'
04/04/22 BTIG
Gracell initiated with a Buy at BTIG
03/14/22 Piper Sandler
Gracell price target lowered to $25 from $40 at Piper Sandler
06/14/21 Piper Sandler
Gracell plans to expand GC012F's clinical profile, says Piper Sandler
GRCL Gracell
$3.00 /

-0.045 (-1.48%)

GRCL Gracell
$3.00 /

-0.045 (-1.48%)

Hot Stocks
SpringsWorks Therapeutics presents Nirogacestat Clinical Data at 2022 ASCO » 18:39
05/26/22
05/26
18:39
05/26/22
18:39
SWTX

SpringsWorks Therapeutics

$30.81 /

-1.76 (-5.40%)

, GSK

GlaxoSmithKline

$44.41 /

-0.57 (-1.27%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

05/24/22 Goldman Sachs
SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
03/01/22 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $142 from $137 at H.C. Wainwright
10/27/21 Wedbush
Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
09/08/21 JPMorgan
SpringsWorks price target raised to $105 from $97 at JPMorgan
GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

05/19/22 Deutsche Bank
GlaxoSmithKline price target raised to 1,750 GBp at Deutsche Bank
05/17/22 Roth Capital
Ideaya Biosciences price target raised to $46 from $42 at Roth Capital
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
04/29/22 Barclays
GlaxoSmithKline price target raised to 1,800 GBp from 1,775 GBp at Barclays
SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

GSK GlaxoSmithKline
$44.41 /

-0.57 (-1.27%)

Hot Stocks
Alaunos Therapeutics to present data on TCR-T Library Phase 1/2 trial » 18:36
05/26/22
05/26
18:36
05/26/22
18:36
TCRT

Alaunos Therapeutics

/

+

Alaunos Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCRT Alaunos Therapeutics
/

+

TCRT Alaunos Therapeutics
/

+

05/04/22 Wells Fargo
Wells Fargo upgrades Alaunos Therapeutics to Overweight with $3 price target
05/04/22 Wells Fargo
Alaunos upgraded to Overweight from Equal Weight at Wells Fargo
TCRT Alaunos Therapeutics
/

+

TCRT Alaunos Therapeutics
/

+

Earnings
Loop Industries reports FY22 EPS (99c), consensus (88c) » 18:36
05/26/22
05/26
18:36
05/26/22
18:36
LOOP

Loop Industries

$5.53 /

+0.04 (+0.73%)

Daniel Solomita, Founder…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOOP Loop Industries
$5.53 /

+0.04 (+0.73%)

LOOP Loop Industries
$5.53 /

+0.04 (+0.73%)

10/28/21 Raymond James
Loop Industries initiated with an Outperform at Raymond James
10/07/21 H.C. Wainwright
Loop Industries upgraded to Buy from Neutral at H.C. Wainwright
LOOP Loop Industries
$5.53 /

+0.04 (+0.73%)

Hot Stocks
Xencor reports initial dose-escalation Phase 1 data of XmAb 104 » 18:32
05/26/22
05/26
18:32
05/26/22
18:32
XNCR

Xencor

$22.36 /

+0.03 (+0.13%)

Xencor reported initial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XNCR Xencor
$22.36 /

+0.03 (+0.13%)

XNCR Xencor
$22.36 /

+0.03 (+0.13%)

05/23/22 Piper Sandler
Xencor price target lowered to $42 from $66 at Piper Sandler
05/06/22 Piper Sandler
Xencor price target lowered to $66 from $71 at Piper Sandler
02/24/22 H.C. Wainwright
Xencor price target lowered to $55 from $61 at H.C. Wainwright
02/10/22 BMO Capital
Xencor initiated with an Outperform at BMO Capital
XNCR Xencor
$22.36 /

+0.03 (+0.13%)

On The Fly
Fly Intel: After-Hours Movers » 18:31
05/26/22
05/26
18:31
05/26/22
18:31
RRGB

Red Robin

$8.61 /

+0.6 (+7.49%)

, ULTA

Ulta Beauty

$378.10 /

+25.03 (+7.09%)

, DELL

Dell Technologies

$44.00 /

+0.705 (+1.63%)

, MRVL

Marvell

$56.90 /

+2.93 (+5.43%)

, ADSK

Autodesk

$191.37 /

+4.92 (+2.64%)

, ACET

Adicet Bio

$10.23 /

+0.04 (+0.39%)

, PMVP

PMV Pharmaceuticals

$13.21 /

+0.125 (+0.96%)

, ZYME

Zymeworks

$6.35 /

+0.44 (+7.45%)

, PDSB

PDS Biotechnology

$4.99 /

-0.06 (-1.19%)

, GPS

Gap

$11.15 /

+0.5 (+4.69%)

, AEO

American Eagle

$13.99 /

+0.425 (+3.13%)

, WDAY

Workday

$168.04 /

+3.57 (+2.17%)

, COST

Costco

$465.33 /

+25.32 (+5.75%)

, IOVA

Iovance Biotherapeutics

$15.11 /

+0.325 (+2.20%)

, SWTX

SpringsWorks Therapeutics

$30.81 /

-1.76 (-5.40%)

, MRTX

Mirati Therapeutics

$58.42 /

+0.43 (+0.74%)

ShowHide Related Items >><<
RRGB Red Robin
$8.61 /

+0.6 (+7.49%)

ULTA Ulta Beauty
$378.10 /

+25.03 (+7.09%)

DELL Dell Technologies
$44.00 /

+0.705 (+1.63%)

MRVL Marvell
$56.90 /

+2.93 (+5.43%)

ADSK Autodesk
$191.37 /

+4.92 (+2.64%)

ACET Adicet Bio
$10.23 /

+0.04 (+0.39%)

PMVP PMV Pharmaceuticals
$13.21 /

+0.125 (+0.96%)

ZYME Zymeworks
$6.35 /

+0.44 (+7.45%)

PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

GPS Gap
$11.15 /

+0.5 (+4.69%)

AEO American Eagle
$13.99 /

+0.425 (+3.13%)

WDAY Workday
$168.04 /

+3.57 (+2.17%)

COST Costco
$465.33 /

+25.32 (+5.75%)

IOVA Iovance Biotherapeutics
$15.11 /

+0.325 (+2.20%)

SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

MRTX Mirati Therapeutics
$58.42 /

+0.43 (+0.74%)

RRGB Red Robin
$8.61 /

+0.6 (+7.49%)

04/18/22 Raymond James
Red Robin downgraded to Market Perform from Outperform at Raymond James
04/18/22 Raymond James
Red Robin downgraded to Market Perform from Outperform at Raymond James
11/23/21 Benchmark
Red Robin initiated with a Buy at Benchmark
11/11/21 Raymond James
Red Robin price target lowered to $30 from $40 at Raymond James
ULTA Ulta Beauty
$378.10 /

+25.03 (+7.09%)

05/25/22 Deutsche Bank
Ulta Beauty price target lowered to $466 from $522 at Deutsche Bank
04/19/22 Piper Sandler
Ulta Beauty price target lowered to $465 from $475 at Piper Sandler
04/06/22 Piper Sandler
Piper lists winners and losers from semi-annual teen survey
03/16/22 Oppenheimer
Estee Lauder price target lowered to $300 from $350 at Oppenheimer
DELL Dell Technologies
$44.00 /

+0.705 (+1.63%)

05/25/22 Evercore ISI
Dell Technologies added to 'Tactical Outperform' list at Evercore ISI
05/25/22 JPMorgan
Dell Technologies price target lowered to $60 from $68 at JPMorgan
05/23/22 Citi
Dell Technologies price target lowered to $65 from $70 at Citi
04/19/22 KGI Securities
Dell Technologies initiated with a Neutral at KGI Securities
MRVL Marvell
$56.90 /

+2.93 (+5.43%)

05/25/22 Susquehanna
Marvell price target lowered to $90 from $105 at Susquehanna
05/23/22 B. Riley
Marvell price target lowered to $72 from $95 at B. Riley
05/23/22 UBS
Marvell price target lowered to $80 from $95 at UBS
05/20/22 Oppenheimer
Marvell price target lowered to $90 from $110 at Oppenheimer
ADSK Autodesk
$191.37 /

+4.92 (+2.64%)

05/23/22 Stifel
Autodesk price target lowered to $230 from $285 at Stifel
05/23/22 RBC Capital
Autodesk price target lowered to $255 from $295 at RBC Capital
05/23/22 Deutsche Bank
Deutsche Bank downgrades Autodesk on risk to consensus estimates
05/23/22 Deutsche Bank
Autodesk downgraded to Hold from Buy at Deutsche Bank
ACET Adicet Bio
$10.23 /

+0.04 (+0.39%)

03/30/22 SMBC Nikko
Adicet Bio initiated with an Outperform at SMBC Nikko
03/17/22 JMP Securities
Adicet Bio price target lowered to $21 from $30 at JMP Securities
03/08/22 Truist
Adicet Bio initiated with a Buy at Truist
03/04/22 Jefferies
Adicet Bio initiated with a Buy at Jefferies
PMVP PMV Pharmaceuticals
$13.21 /

+0.125 (+0.96%)

03/02/22 Oppenheimer
Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target
03/02/22 Oppenheimer
PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
09/22/21 Goldman Sachs
PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
08/19/21 Oppenheimer
PMV Pharmaceuticals initiated with a Perform at Oppenheimer
ZYME Zymeworks
$6.35 /

+0.44 (+7.45%)

05/23/22 H.C. Wainwright
Zymeworks price target lowered to $40 from $44 at H.C. Wainwright
05/09/22 Citi
Zymeworks should reject 'opportunistic' $10.50 per share offer, says Citi
05/05/22 Guggenheim
Zymeworks upgraded to Buy at Guggenheim amid low expectations
05/05/22 Guggenheim
Zymeworks upgraded to Buy from Neutral at Guggenheim
PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

05/13/22 Alliance Global Partners
PDS Biotechnology price target lowered to $16 from $18 at Alliance Global Partners
10/21/21 H.C. Wainwright
H.C. Wainwright says PDS Biotechnology temporary hold shouldn't spark concerns
08/12/21 H.C. Wainwright
PDS Biotechnology price target lowered to $15 from $20 at H.C. Wainwright
06/28/21 Cantor Fitzgerald
PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald
GPS Gap
$11.15 /

+0.5 (+4.69%)

05/23/22 Citi
Gap downgraded to Sell from Neutral at Citi
05/17/22 UBS
Gap price target lowered to $14 from $18 at UBS
05/16/22 JPMorgan
Gap price target lowered to $11 from $14 at JPMorgan
04/25/22 Guggenheim
Guggenheim upgrades Gap to Buy with shares 70% off highs
AEO American Eagle
$13.99 /

+0.425 (+3.13%)

05/23/22 Citi
American Eagle downgraded to Neutral from Buy at Citi
05/17/22 B. Riley
American Eagle price target lowered to $32 from $41 at B. Riley
05/16/22 JPMorgan
American Eagle price target lowered to $20 from $29 at JPMorgan
04/11/22 JPMorgan
American Eagle price target lowered to $29 from $32 at JPMorgan
WDAY Workday
$168.04 /

+3.57 (+2.17%)

05/23/22 Cowen
Workday price target lowered to $250 from $310 at Cowen
05/20/22 DA Davidson
Workday price target lowered to $250 from $300 at DA Davidson
05/20/22 Barclays
Workday price target lowered to $238 from $319 at Barclays
05/18/22 Wells Fargo
Workday price target lowered to $300 from $340 at Wells Fargo
COST Costco
$465.33 /

+25.32 (+5.75%)

05/25/22 Deutsche Bank
Costco price target lowered to $525 from $530 at Deutsche Bank
05/20/22 Oppenheimer
Costco price target lowered to $500 from $645 at Oppenheimer
05/19/22 Truist
Costco price target lowered to $503 from $634 at Truist
05/19/22 Stifel
Costco price target lowered to $515 from $565 at Stifel
IOVA Iovance Biotherapeutics
$15.11 /

+0.325 (+2.20%)

04/07/22 Truist
Iovance Biotherapeutics price target lowered to $29 from $32 at Truist
04/07/22 Baird
Iovance Biotherapeutics price target raised to $34 from $30
04/06/22 Oppenheimer
Iovance 'good news' offset by timeline delay, says Oppenheimer
04/06/22 Goldman Sachs
Iovance commentary supports potency assay progress, says Goldman Sachs
SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

05/24/22 Goldman Sachs
SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
03/01/22 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $142 from $137 at H.C. Wainwright
10/27/21 Wedbush
Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
09/08/21 JPMorgan
SpringsWorks price target raised to $105 from $97 at JPMorgan
MRTX Mirati Therapeutics
$58.42 /

+0.43 (+0.74%)

05/20/22 Guggenheim
Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
05/20/22 Guggenheim
Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim
05/05/22 Stifel
ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
05/05/22 Citi
Mirati Therapeutics price target lowered to $208 from $227 at Citi
RRGB Red Robin
$8.61 /

+0.6 (+7.49%)

ULTA Ulta Beauty
$378.10 /

+25.03 (+7.09%)

DELL Dell Technologies
$44.00 /

+0.705 (+1.63%)

MRVL Marvell
$56.90 /

+2.93 (+5.43%)

ADSK Autodesk
$191.37 /

+4.92 (+2.64%)

ACET Adicet Bio
$10.23 /

+0.04 (+0.39%)

PMVP PMV Pharmaceuticals
$13.21 /

+0.125 (+0.96%)

ZYME Zymeworks
$6.35 /

+0.44 (+7.45%)

PDSB PDS Biotechnology
$4.99 /

-0.06 (-1.19%)

GPS Gap
$11.15 /

+0.5 (+4.69%)

AEO American Eagle
$13.99 /

+0.425 (+3.13%)

WDAY Workday
$168.04 /

+3.57 (+2.17%)

COST Costco
$465.33 /

+25.32 (+5.75%)

IOVA Iovance Biotherapeutics
$15.11 /

+0.325 (+2.20%)

SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

MRTX Mirati Therapeutics
$58.42 /

+0.43 (+0.74%)

  • 27
    Jan
  • 08
    Dec
  • 11
    Nov
  • 15
    Jun
DELL Dell Technologies
$44.00 /

+0.705 (+1.63%)

PMVP PMV Pharmaceuticals
$13.21 /

+0.125 (+0.96%)

GPS Gap
$11.15 /

+0.5 (+4.69%)

WDAY Workday
$168.04 /

+3.57 (+2.17%)

RRGB Red Robin
$8.61 /

+0.6 (+7.49%)

ULTA Ulta Beauty
$378.10 /

+25.03 (+7.09%)

DELL Dell Technologies
$44.00 /

+0.705 (+1.63%)

MRVL Marvell
$56.90 /

+2.93 (+5.43%)

ADSK Autodesk
$191.37 /

+4.92 (+2.64%)

ACET Adicet Bio
$10.23 /

+0.04 (+0.39%)

ZYME Zymeworks
$6.35 /

+0.44 (+7.45%)

GPS Gap
$11.15 /

+0.5 (+4.69%)

AEO American Eagle
$13.99 /

+0.425 (+3.13%)

WDAY Workday
$168.04 /

+3.57 (+2.17%)

COST Costco
$465.33 /

+25.32 (+5.75%)

IOVA Iovance Biotherapeutics
$15.11 /

+0.325 (+2.20%)

SWTX SpringsWorks Therapeutics
$30.81 /

-1.76 (-5.40%)

MRTX Mirati Therapeutics
$58.42 /

+0.43 (+0.74%)

ULTA Ulta Beauty
$378.10 /

+25.03 (+7.09%)

DELL Dell Technologies
$44.00 /

+0.705 (+1.63%)

MRVL Marvell
$56.90 /

+2.93 (+5.43%)

ADSK Autodesk
$191.37 /

+4.92 (+2.64%)

GPS Gap
$11.15 /

+0.5 (+4.69%)

AEO American Eagle
$13.99 /

+0.425 (+3.13%)

WDAY Workday
$168.04 /

+3.57 (+2.17%)

COST Costco
$465.33 /

+25.32 (+5.75%)

IOVA Iovance Biotherapeutics
$15.11 /

+0.325 (+2.20%)

Hot Stocks
Spectrum to present data on poziotinib in NSCLC at ASCO Meeting » 18:28
05/26/22
05/26
18:28
05/26/22
18:28
SPPI

Spectrum

/

+

Spectrum Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPPI Spectrum
/

+

SPPI Spectrum
/

+

03/21/22 B. Riley
Spectrum price target lowered to $4 from $6 at B. Riley
08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
SPPI Spectrum
/

+

SPPI Spectrum
/

+

SPPI Spectrum
/

+

Hot Stocks
Amgen to present new data from oncology pipeline at ASCO » 18:26
05/26/22
05/26
18:26
05/26/22
18:26
AMGN

Amgen

$253.01 /

+0.05 (+0.02%)

, TAK

Takeda Pharmaceutical

$14.84 /

-0.06 (-0.40%)

Results From the PARADIGM…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$253.01 /

+0.05 (+0.02%)

TAK Takeda Pharmaceutical
$14.84 /

-0.06 (-0.40%)

AMGN Amgen
$253.01 /

+0.05 (+0.02%)

05/23/22 SVB Leerink
Radius Health initiated with a Market Perform at SVB Leerink
05/23/22 SVB Leerink
Amgen initiated with a Market Perform at SVB Leerink
05/10/22 Mizuho
Amgen price target raised to $208 from $202 at Mizuho
05/05/22 Stifel
ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
TAK Takeda Pharmaceutical
$14.84 /

-0.06 (-0.40%)

05/13/22 BTIG
Poseida Therapeutics price target lowered to $20 from $40 at BTIG
03/31/22 Canaccord
Canaccord starts Morphic at Buy, sees potential to take share from Takeda
02/11/22 BTIG
Protagonist Therapeutics initiated with a Buy at BTIG
02/11/22 BTIG
Morphic initiated with a Buy at BTIG
AMGN Amgen
$253.01 /

+0.05 (+0.02%)

AMGN Amgen
$253.01 /

+0.05 (+0.02%)

TAK Takeda Pharmaceutical
$14.84 /

-0.06 (-0.40%)

AMGN Amgen
$253.01 /

+0.05 (+0.02%)

TAK Takeda Pharmaceutical
$14.84 /

-0.06 (-0.40%)

AMGN Amgen
$253.01 /

+0.05 (+0.02%)

Hot Stocks
Eli Lilly to present data on oncology portfolio » 18:21
05/26/22
05/26
18:21
05/26/22
18:21
LLY

Eli Lilly

$313.34 /

+6.24 (+2.03%)

Eli Lilly announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$313.34 /

+6.24 (+2.03%)

LLY Eli Lilly
$313.34 /

+6.24 (+2.03%)

05/23/22 SVB Leerink
Eli Lilly initiated with an Outperform at SVB Leerink
05/02/22 Wells Fargo
AbbVie price target raised to $200 from $165 at Wells Fargo
05/02/22 Mizuho
Eli Lilly price target raised to $356 from $315 at Mizuho
04/29/22 Morgan Stanley
Eli Lilly price target raised to $369 from $364 at Morgan Stanley
LLY Eli Lilly
$313.34 /

+6.24 (+2.03%)

LLY Eli Lilly
$313.34 /

+6.24 (+2.03%)

LLY Eli Lilly
$313.34 /

+6.24 (+2.03%)

LLY Eli Lilly
$313.34 /

+6.24 (+2.03%)

Hot Stocks
CTI BioPharma to present pivotal data on pacritinib program » 18:19
05/26/22
05/26
18:19
05/26/22
18:19
CTIC

CTI BioPharma

$5.28 /

-0.03 (-0.56%)

CTI BioPharma announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTIC CTI BioPharma
$5.28 /

-0.03 (-0.56%)

CTIC CTI BioPharma
$5.28 /

-0.03 (-0.56%)

04/14/22 Stifel
Stifel reiterates Buy on CTI BioPharma following new treatment guidelines
03/01/22 Brookline
CTI BioPharma price target raised to $12 from $7.20 at Brookline
12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
CTIC CTI BioPharma
$5.28 /

-0.03 (-0.56%)

CTIC CTI BioPharma
$5.28 /

-0.03 (-0.56%)

CTIC CTI BioPharma
$5.28 /

-0.03 (-0.56%)

Hot Stocks
Cue Biopharma to present interim data on CUE-101 in head and neck cancer » 18:17
05/26/22
05/26
18:17
05/26/22
18:17
CUE

Cue Biopharma

$3.58 /

-0.075 (-2.05%)

Cue Biopharma will give a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CUE Cue Biopharma
$3.58 /

-0.075 (-2.05%)

CUE Cue Biopharma
$3.58 /

-0.075 (-2.05%)

03/23/22 JMP Securities
Cue Biopharma price target lowered to $15 from $30 at JMP Securities
03/21/22 Oppenheimer
Cue Biopharma price target lowered to $26 from $32 at Oppenheimer
03/18/22 Craig-Hallum
Nektar failure 'not necessarily' a read through to Cue, says Craig-Hallum
01/03/22 Craig-Hallum
Craig-Hallum bullish on Cue Biopharma, initiates with a Buy
CUE Cue Biopharma
$3.58 /

-0.075 (-2.05%)

Hot Stocks
Ipsen's Cabometyx shows 'encouraging' efficacy results in different tumor types » 18:15
05/26/22
05/26
18:15
05/26/22
18:15
IPSEY

Ipsen

$25.81 /

+ (+0.00%)

Ipsen announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$25.81 /

+ (+0.00%)

IPSEY Ipsen
$25.81 /

+ (+0.00%)

04/29/22 Societe Generale
Ipsen price target raised to EUR 120 from EUR 112 at Societe Generale
04/28/22 JPMorgan
Ipsen price target raised to EUR 91 from EUR 88 at JPMorgan
04/27/22 Bryan Garnier
Ipsen downgraded to Neutral from Buy at Bryan Garnier
04/14/22 Barclays
Ipsen price target raised to EUR 95 from EUR 88 at Barclays
IPSEY Ipsen
$25.81 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.